Although the quality of palliative care in England and the wider UK is regarded as excellent, many patients receiving palliative care die in pain. This new study estimates that more than 5,000 patients would die in pain every year even under the ‘best practice’ palliative care such as that provided in hospices.
In England, an estimated 378,427 people receive palliative care each year in a range of specialised and generalised services. Overall, the quality of palliative care in England and the wider UK is widely regarded as excellent. However, despite the generally high level of care, many patients receiving palliative care die in pain every year. Yet, to date, there is little evidence of the scale of this problem. This study estimates that currently there are approximately 125,971 end-of-life patients receiving, or in need of, palliative care suffering from unrelieved pain.
At the recent ISPOR Annual Conference, OHE’s Chief Executive, Professor Graham Cookson announced a new programme of work on Value 2.0: Assessing the Value of US Healthcare to be funded by PhRMA. Graham was joined by the Innovation and Value Institute’s Executive Director Jenn Bright, and Harvard Medical School Professor Bapu Jena.
A key objective for financially-constrained health care systems is to extract better value from the budgets available, by encouraging the delivery of high-quality health care at the lowest feasible cost.
Research just published in Public Administration Review, co-authored by OHE’s Professor Graham Cookson, demonstrates that contracting out auxiliary public services may lower the quality of the core service as well as the auxiliary service. Studying NHS cleaning services, the research shows that contracted out cleaning is cheaper but lower quality and leads to worse health outcomes including higher rates of hospital-acquired infections.
OHE Lunchtime Seminar with NHS Improvement Economics Team Members Sarah Karlsberg, Steven Paling and Júlia Esquerré. The seminar will present evidence on where NHS trusts can take practical steps to reduce cancer waiting times. The project won the 2018 John Hoy Memorial Award for the best piece of economic analysis produced by government economists.
The latest publication from Professor Graham Cookson in Public Organization Review finds that waiting time targets adopted in the English NHS as part of the ‘targets and terror’ performance management regime did indeed reduce key waiting time measures, but at the expense of other quality metrics such as hospital readmission rates i.e. the policy was output distorting.
OHE Lunchtime Seminar with Dr. Aslam Anis, The University of British Columbia. The seminar will discuss the impact of the pan-Canadian Pharmaceutical Alliance “tiered pricing” framework (a flexible 'price-cap' regulation) on generic entry, the resulting drug expenditure levels from a drug plans’ perspective and the implications of price-capping policies on drug shortages.